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Objectives: To assess the prevalence of polyps in patients with a family history of colorectal
cancer, in comparison to asymptomatic individuals with indication for screening.
Methods: A prospective study in a group of patients who underwent colonoscopy between
2012 and 2014. Patients were divided into two groups: Group I: no family history of colorectal
cancer, and Group II: with a family history in ﬁrst-degree relatives. Demographic charac-
teristics, ﬁndings on colonoscopy, presence, location and histological type of polyps were
evaluated, comparing the two groups.
Results: 214 patients were evaluated: 162 in Group I and 52 in Group II. The distribution of
patients with polyps was similar in relation to gender: polyps were evidenced in Group I
in  33 (20%) female patients vs. 10 (6%) male patients (p = 1.00); in Group II, the presence of
polyps was evidenced in 9 (17%) female patients vs. 2 (4%) male patients (p = 1.00). Polypoid
lesions were found in 54 patients (25%), with 43 (26%) in Group I and 11 (21%) in Group II. The
prevalence of adenomas was similar in both groups (Group I = 18/37% vs. Group II = 10/50%)
(p  = 0.83).
Conclusion: In this preliminary study, no correlation was found between prevalence of polyps
and  a family history of colorectal cancer.©  2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. Allrights reserved.
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A  prevalência  de  pólipos  colorretais  é  mais  elevada  em  pacientes  com
história  familiar  de  câncer  colorretal?
Palavras-chave:
Videocolonoscopia
Pólipos
Prevenc¸ão
Câncer colorretal
r  e  s  u  m  o
Objetivos: Avaliar a prevalência de pólipos em pacientes com história familiar de câncer
colorretal comparando com indivíduos assintomáticos com indicac¸ão para rastreamento.
Métodos: Estudo prospectivo realizado em um grupo de indivíduos submetidos à colono-
scopia entre 2012 e 2014. Os pacientes foram distribuídos em dois grupos: Grupo I:
sem  história familiar de câncer colorretal e Grupo II: com história familiar em parentes
de  primeiro grau. Avaliaram-se características demográﬁcas, achados na colonoscopia,
presenc¸a,  localizac¸ão e tipo histológico dos pólipos, comparando os dois grupos.
Resultados: Foram avaliados 214 pacientes, 162 incluídas no grupo I e 52 no grupo II. A
distribuic¸ão  dos pacientes com pólipos foi similar em relac¸ão ao sexo, sendo evidenciado
pólipos no Grupo I em 33 (20%) pacientes do sexo feminino vs. 10 (6%) masculino (p = 1,00)
e  no Grupo II, presenc¸a de pólipos em pacientes do sexo feminino em 9 (17%) vs. 2 (4%)
masculino (p = 1,00). Foram encontradas lesões polipóides em 54 pacientes (25%), sendo 43
(26%) no grupo I e 11 (21%) no grupo II. A prevalência de adenomas foi similar em ambos os
grupos (Grupo I = 18/37% vs. Grupo II = 10/50%) (p = 0,83).
Conclusão: Neste estudo inicial, não foi encontrada correlac¸ão entre a prevalência de pólipos
e  o histórico familiar de câncer colorretal.
© 2015 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos os direitos reservados.
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olorectal cancer (CRC) is the third most common cause of
ancer worldwide in both genders and the second leading
ause in developed countries.1 In Brazil, the estimated inci-
ence for the year 2014 is 15.44 and 17.24 new cases per
00,000 men  and women, respectively.2 It is well established
hat the great majority of CRC cases (adenocarcinomas) is due
o benign tumors (adenomas), a process known as adenoma-
arcinoma sequence, originally described by Vogelstein.3
Twenty-ﬁve percent of CRC cases occur in individuals with
t least one ﬁrst-degree relative (FDR) with a diagnosis of
RC not associated with a known genetic syndrome.4 These
ndividuals have, on average, twice the risk vs. general popu-
ation’s risk to develop CRC in their lifetime.5
Patients with CRC and their families are candidates for
ifferent screening strategies, thanks to the increased risk
f developing colorectal cancer and to the possibility of pri-
ary and secondary prevention, allowing for a longer survival
or patients treated in the early stages of this disease.6
ecent studies have favored colonoscopy as the best screening
ethod, for allowing diagnosis and treatment of precursor
esions and obtaining biopsies of suspicious lesions.7,8
Currently, the reality of public health in Brazil, espe-
ially in Northeast Region, does not allow full access to
olonoscopy screening tests for the whole asymptomatic pop-
lation (including those with a family history) from the age of
0 to 50 years onward.
In the same line, there are few studies evaluating the spe-
iﬁc group of asymptomatic individuals with no family history.
herefore, studies are needed to assess the prevalence of these
recursor lesions, aiming to demonstrate, for this popula-
ion, the beneﬁts of a screening strategy. This study aims toassess the prevalence of polyps in patients with family history
of colorectal cancer, compared to asymptomatic individuals
undergoing colonoscopy with indication for a screening pro-
cedure.
Methodology
This is a cross-sectional, analytical, prospective, compara-
tive study, including asymptomatic patients who  underwent
screening colonoscopy at the Hospital Universitário Walter
Cantídio, Universidade Federal do Ceará (HUWC/UFC) and at
the Coloproctology Center, Hospital São Carlos, in the city of
Fortaleza – Ceará, from January 2012 to January 2014. Partici-
pants were divided into two groups: Group I – without family
history of CRC, and Group II – with a family history of spo-
radic CRC in FDR. Screening colonoscopy was indicated for
patients aged from 50 years onward in asymptomatic indi-
viduals without family history (Group I), and for those aged
from 40 years onward, or 10 years before CRC diagnosis age
in younger individuals, in patients with family history (Group
II).
Demographic characteristics such as age, gender, body
mass index (BMI) and family history of CRC, as well as data
obtained with colonoscopy (quality of colon preparation [good,
optimal or bad]), progression of the device until reaching
cecum (full examination), presence of polyps, and histopatho-
logical examination (histology type for polyps). The study was
approved by the Ethics Committee of Hospital UniversitárioPatients with family history of familial adenomatous
polyposis (FAP); hereditary nonpolyposis colorectal cancer
(HNPCRC) according to Amsterdam criteria II9; with a known
j). 2 0148  j coloproctol (rio 
genetic syndrome that arguably increases CRC risk; individ-
uals with a history of colorectal surgery for any cause; with a
diagnosis of inﬂammatory bowel disease (IBD); immunosup-
pressed individuals, or with symptoms related to colorectal
disorders were excluded.
For an evaluation of numerical variables, Student t, Fisher
and Chi-squared tests were used. The statistical signiﬁcance
level was set at p < 0.05.
Results
A total of 214 patients were included: 47 (22%) male and 167
(78%) female. As for the assessment of body mass index (BMI),
87 (40%) were eutrophic, 67 (31%) with overweight and 60
(28%) were obese patients. In 183 (86%) colonoscopies, the
colon was visualized in its entirety, and a good and optimal
preparation was described in 62% of tests. In 54 (25%) proce-
dures, a total of 69 colonic polyps were found. The localization
of the polyps was: rectum (18/26% polyps), ascending colon
(12/17% polyps), descending colon (11/16% polyps), and cecum,
transverse colon and sigmoid (10/14.5% 10/14.5% 8/12% polyps,
respectively).
From the total of 214 individuals, 162 (76%) were included in
Group I (mean age, 56 years; of these, 125 (77%) were female. In
Group II, 52 (24%) patients were included (mean age, 54 years);
Table 1 – Characteristics of patients comparing groups with fam
With no familiar history of CRC 
Group I 
n (%) 
Age 56 ± 12 
Gender
Male 37 (23%) 
Female 125 (77%) 
Presence of polyps 43 (26%) 
Location of polyps
Caecum 8 (16%) 
Ascending colon 8 (16%) 
Transverse colon 7 (15%) 
Descending colon 8 (16%) 
Sigmoid 5 (10%) 
Rectum 13 (27%) 
Total number of patients 162 (76%) 
CRC, colorectal cancer.
Table 2 – Prevalence of polyps distributed between genders in g
cancer.
Total number of patients Without 
Group I
162
27
92
Group II
52
08
33
M, male; F, female.
Male patients from Group I vs. Group II (10/6% vs. 2/4%, p = 1.00).
Female patients from Group I vs. Group II (33/20% vs. 9/17%, p = 0.68). 1 5;3  5(3):146–150
of these, 42 (81%) were female. No statistical difference was
noted between groups, regarding age and gender (Table 1).
Colonoscopy  and  histopathology  ﬁndings
In Group I, polyps were seen in 43 (26%) of the 162 examined
patients. In Group II, from 52 examinations performed, polyps
were found in 11 (21%) patients, without statistical difference
between groups (p = 0.47). The location of the polyps in colonic
areas was similar in both groups (Table 1).
As to gender, the distribution of patients with polyps was
similar; in Group I, polyps were evidenced in 33 (20%) female
vs. 10 (6%) male patients (p = 1.00). In Group II, polyps were
evidenced in 9 (17%) female vs. 2 (4%) male patients (p = 1.00).
When comparing groups, no difference was identiﬁed in terms
of prevalence of polyps by gender, as follows: male gender in
Group I vs. Group II (10/6% vs. 2/4%, p = 1.00) and female gender
in Group I vs. Group II (33/20% vs. 9/17%, p = 0.68) (Table 2). The
mean size of polyps in Group I was 0.4 cm,  while in Group II
was 0.3 cm.
As to the histology of polyps in Group I, in those 43 patients
with polyps, a total of 49 polyps was demonstrated, as fol-
lows: 18 (37%) adenomatous, 23 (47%) hyperplastic and 8 (16%)
inﬂammatory polyps. In Group II, a total of 20 polyps were
identiﬁed in 11 patients with positive colonoscopy for pres-
ence of polyps, as follows: 9 (45%) adenomatous, 10 (50%)
ily history vs. no family story for colorectal cancer.
With a positive familiar history for CRC p
Group II
n (%)
54 ± 10 0.60
10 (19%) 0.70
42 (81%)
11 (21%) 0.47
2 (10%) 0.71
4 (20%) 0.73
3 (15%) 1.00
3 (15%) 1.00
3 (15%) 0.68
5 (25%) 1.00
52 (24%)
roups with no family history vs. family story of colorectal
polyps Gender With  polyps Gender
 M 10 M
 F 33 F
 M 02 M
 F 09 F
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Table 3 – Histological subtypes of polyps comparing groups with vs. without family history of colorectal cancer.
Patients n (%) Adenomatous n (%) Hyperplastic n (%) Inﬂammatory n (%) Polyps na (%)
Group I 43 (26%) 18 (37%) 23 (47%) 08 (16%) 49 (71%)
Group II 11 (21%) 09 (45%) 10 (50%) 01 (5%) 20 (29%)
p = 0.83.
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wa In some tests, more than one polypectomy was performed, which
the number of exams with polyp.
yperplastic and 1 (5%) inﬂammatory polyps, with no statisti-
ally signiﬁcant difference (p = 0.83) between groups (Table 3).
iscussion
he risk of developing CRC is of 5%, with an increased risk for
eople who  have close relatives with CRC, especially if diag-
osed at an early age.10,11 Depending on the family history
nd the presence of an inherited mutation for CRC, the risk
ariability for this neoplasia can reach up to 70%.11 Screening
rograms, including colonoscopy, in individuals with familial
RC as well as in the population in general, reduce the inci-
ence of neoplasia and appear to prevent CRC mortality.7,12,13
here is still much discussion to determine if the prevalence
nd frequency of adenomas in individuals with a family his-
ory of CRC are higher than in the general population.14–17
This study evaluated the prevalence of polyps in asymp-
omatic patients with CRC history in ﬁrst-degree relatives
Group I) and compared its ﬁndings vs. an asymptomatic pop-
lation with no family history (Group II) who performed their
rst examination with indication for screening purposes. It
as been shown that the distribution of polyps was similar
n both groups, and no evidence of a correlation was found
etween the number of polyps and patients’ gender, since
he distribution of the polyps was similar in a comparison of
emale vs. male gender in both groups. The largest number
f polyps in females was proportional to the greater num-
er of women in the general population studied, justifying the
imilarity of distribution of polyps by gender.
In this study, “family history” was considered as the pres-
nce of a diagnosis of CRC in ﬁrst-degree relatives, including
he patient’s father, mother and children.18 Using this cri-
erion, the distribution of polyps and the histological type,
ncluding adenomatous polyps, were also similar in both
roups.
By analyzing the data obtained, it was observed that the
umber of women undergoing preventive procedures is still
igher than that in men, which can be explained by men’s
istorical resistance to seek medical services and also by prej-
dices related to colonoscopy procedures in men.
It was also observed that the group with a positive family
istory for CRC (Group II) presented a lower mean age (54 vs.
6 years), when compared to the group with no family history
Group I), but this ﬁnding had no statistical signiﬁcance, even
ith the advice for starting the screening procedure 10 years
efore the age of that relative who  was diagnosed with the
isease.
It was expected a bigger difference between mean ages
hen comparing the two groups. This ﬁnding may reﬂect theﬁes the increased number of histological results when compared to
lack of information and the difﬁculty of monitoring programs
targeted to this risk group in Northeast Region of this country.
Twenty-six percent of individuals with no family history
of CRC (Group I) underwent polypectomy, which is in agree-
ment with the literature, although this percentage can vary
between 17 and 21%, eventually reaching up to 50%, depending
on the age group in question.6,10 In the group with a positive
family history for CRC (Group II), 21% had polyps detected,
with no statistical difference vs. Group I. These results were
similar to those described by Zandoná et al.,19 who evaluated
patients with a family history of colorectal cancer compared
with patients undergoing colonoscopy with a wide range of
indications, showing a percentage of 18% of polyps in the
group with a positive family history and 14% in the population
with an indication for colonoscopic evaluation.
In a multicenter study, the histology revealed that
37.5% of polyps were adenomatous, most of them tubular
adenomas.6,10 In an analysis of types of polyps in Groups I and
II, our data were similar (37% and 45% of adenomatous polyps,
respectively). Corroborating the results of this study, Zan-
doná et al.19 conﬁrmed that there was no statistical difference
in the prevalence of adenomatous polyps, when comparing
patients with a positive family history for CRC vs. symp-
tomatic patients and/or individuals with an indication for
colonoscopy.
As to the location of polyps, it is known that an examina-
tion of the distal colon (rectum, sigmoid colon, and descending
colon) can detect 60–80% of the polyps.6 In this study, approxi-
mately 54% of the polyps were located in left colon and rectum
in both groups, which is in agreement with the literature. How-
ever, it is important to note that when one evaluates only the
rectum and sigmoid, this percentage of polyp detection, or
even of malignant lesion detection, can fall to 40%.8 These data
reinforce the importance of a full colonoscopy, and not only a
ﬂexible rectosigmoidoscopy, as a method of detecting polyps
and for prevention of CRC. Studies show that colonoscopy is
considered the method of choice for early detection of colo-
rectal cancer.6,20 However, this is not a method available in
all services, not covering even all patients with indications for
this type of assessment.
Notwithstanding the clinical relevance of the subject,
this study presents a small number of patients, because
we compared patients with a positive family history for
CRC undergoing colonoscopy vs. an asymptomatic population
undergoing screening for early detection of colorectal cancer.
In a scenario of public services, there is still a huge difﬁculty
in providing colonoscopy as a screening method for CRC, in
a scenario in which the preference for this procedure goes to
symptomatic patients. However, it is critical to expand this
series by adding new patients, in order to conﬁrm the results
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obtained, as well as for comparison with other reference cen-
ters.
Conclusion
In this preliminary study, no correlation between the preva-
lence of polyps and presence of a family history for CRC was
evidenced, since the prevalence and distribution of polyps
according to gender and histologic subtype of this group were
similar to the population of patients with no family history,
who  were examined with an indication for CCR screening.
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